Inbrain Neuroelectronics is a neurotechnology company developing breakthrough neuroelectronic therapies to decode and modulate neural networks. The company combines graphene-based, skin-like brain-computer interfaces with an implantable neural processor to provide high-resolution, bidirectional neural interfacing and real-time neural decoding in a closed-loop system. Their end-to-end platform integrates hardware and data analytics to personalize therapy and improve outcomes for patients, with a focus on neurological disorders and conditions such as Parkinson’s disease. Headquartered in Barcelona, Spain, Inbrain emphasizes advancing safe, scalable neural therapies and has received FDA Breakthrough Device designation for its work in Parkinson’s disease.
No recent deals for this company.